Thermo Fisher Scientific Inc. (TMO) received a 62% rating from Validea's Multi-Factor Investor model, based on Pim van Vliet's low-volatility strategy, which evaluates stocks on fundamentals and valuation. This score falls below the 80% threshold typically indicating investment interest, resulting in a 'FAIL' for TMO under this specific guru strategy.
Thermo Fisher Scientific Inc. (TMO) received a "FAIL" rating with a 62% score from Validea's Multi-Factor Investor model, based on Pim van Vliet's strategy. This score falls significantly below the 80% threshold typically indicating investment interest, signaling a moderately negative assessment from this specific quantitative framework. This aligns with the overall moderately negative sentiment score of -0.5. The Multi-Factor Investor model targets low volatility stocks exhibiting strong momentum and high net payout yields. While TMO, a large-cap growth stock in the Medical Equipment & Supplies industry, passed criteria for market capitalization and standard deviation, it registered "NEUTRAL" for both twelve minus one momentum and net payout yield. These neutral scores on critical factor components appear to be the primary drivers behind the overall 'FAIL' ranking. The analysis highlights that TMO's current profile does not align with the specific low-risk, high-return characteristics sought by this conservative factor investing strategy. Despite TMO's large-cap growth status, its underperformance on momentum and payout yield metrics suggests a potential mismatch for investors strictly adhering to this factor-based approach, indicating a need for further scrutiny within such mandates.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment
